Skip to main navigation Skip to search Skip to main content

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

  • Huy X. Ngo
  • , Ava Y. Xu
  • , Gustavo E. Velásquez
  • , Nan Zhang
  • , Vincent K. Chang
  • , Ekaterina V. Kurbatova
  • , William C. Whitworth
  • , Erin Sizemore
  • , Kia Bryant
  • , Wendy Carr
  • , Marc Weiner
  • , Kelly E. Dooley
  • , Melissa Engle
  • , Susan E. Dorman
  • , Payam Nahid
  • , Susan Swindells
  • , Richard E. Chaisson
  • , Pheona Nsubuga
  • , Madeleine Lourens
  • , Rodney Dawson
    • Radojka M. Savic

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science